Die Inhalte dieser Webseite enthalten Affiliate-Links, für die wir möglicherweise eine Vergütung erhalten.
  • Bild 1

Gefäßstörer zur Behandlung von Krebs von Tim Meyer (Englisch) Ha

Ø 0.0
0 Bewertungen
180,44 €

His major research focus is antibody-based vascular targeting. Judah Folkman (1971) highlighted the potential therapeutic imp- cations of tumor angiogenesis. The subsequent quest for endogenous and exogenous inhibitors of angiogenesis has yielded a variety of promising therapeutic agents that block one or more angiogenic pathways, a few of which have been approved by the FDA (e. g., bevacizumab, sorafenib, sunitinib) for use as single agents or in combination with chemotherapy in specific populations of cancer patients (Sessa et al. 2008).

Jetzt bei Ebay: